3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
106
Neoplasms
14
Neoplasm Metastasis
14
Carcinoma, Non-Small-Cell Lung
4
Advanced Breast Cancer
4
Hereditary Sensory and Autonomic Neuropathies
3
Recurrence
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Multiple Endocrine Neoplasia Type 1
2
Endometrial Neoplasms
2
Breast Neoplasms, Male
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Malignancies
1
Recurrent Uterine Corpus Carcinoma
1
Neoplasms by Site
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
Lethal Congenital Contracture Syndrome 2
1
Hyperglycemia
1
Hormone Receptor Positive HER-2 Negative Breast Cancer
1
Hormone Receptor Positive Breast Cancer
1
HER2-positive Breast Cancer
1
Female Breast Carcinoma
1
Exanthema
1
Interventions
Tamoxifen
6
Radiotherapy
3
Anastrozole
3
Taxes
2
Simvastatin
2
Radiation
2
Paclitaxel
2
Neoadjuvant Therapy
2
Letrozole
2
Gene Expression Profiling
2
Chemotherapy, Adjuvant
2
Celecoxib
2
telapristone acetate
1
poly(I).poly(c12,U)
1
oxybutynin
1
liposomal doxorubicin
1
exemestane
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Yoga
1
Sugars
1
Sentinel Lymph Node Biopsy
1
Ranitidine
1
Radiation Dose Hypofractionation
1
Pharmacogenomic Testing
1
Naltrexone
1
Monitoring, Physiologic
1
Mometasone Furoate
1
Metformin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Carcinoma In Situ
×
Fulvestrant
×
Clear all
No trials found.